United States · FDA National Drug Code directory
mesalamine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70771-1071_26f195e7-e73a-48e7-b3b0-49f7cbed510a
- Product NDC
- 70771-1071
- Form
- TABLET, DELAYED RELEASE
- Composition / generic term
- mesalamine
- Labeler
- Zydus Lifesciences Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170619
- Source listing expiry
- 20261231
Source-listed ingredients
- MESALAMINE — 1.2 g/1
These values do not establish equivalence or a dose recommendation.
Packages
- 120 TABLET, DELAYED RELEASE in 1 BOTTLE (70771-1071-1) · 70771-1071-1
- 34 TABLET, DELAYED RELEASE in 1 BOTTLE (70771-1071-2) · 70771-1071-2
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →